Wednesday, 08 Apr 2020

You are here

RheumNow Podcast - RWCS Quick Hits (2.14.20)

Dr. Jack Cush reviews the highlights from the 2020 RWCS meeting in Maui, Hawaii.

  1. How long will they last? Vast majority of TKR or THR (>70%) will last 25 yrs. Failure is usually for infection or fracture. Dr Wm Bugbee #RWCS2020 @RWCSmtg https://t.co/XyGmeiiQTu
  2. Trends in periop Rx of hip and knee replacement. Little or no narcotics, pain cocktail, tramexamic acid to reduce blood loss & outpt THR ant approach in low risk pts Dr zen Bugbee #RWCS2020 @RheumNow https://t.co/Ky1rD6uHns
  3. “A CDAI of over 40 is fibromyalgia!” In regard to RA patients on therapy. Dr. Cush @RheumNow @RWCSmtg #RWCS20
  4. Shingles vaccine appears to reduce stroke risk by about 16% in older adults. In addition, the shingles vaccine may offer the strongest protection against stroke for people younger than 80 https://t.co/fqHKlHnLED
  5. Poorly regulated industry of Stem cell injx for OA fail to show consistent evidence of efficacy. Dr E Ruderman #RWCS2020 @RWCSmtg https://t.co/poME3BNme3
  6. PRP injections for knee OA may work, but at a very high can 8 price $714. Dr E Ruderman #RWCS2020 @RWCSmtg https://t.co/wmh2iaQ4kt
  7. Leeches work in osteoarthritis, but you won't like the icky side effects. Dr E Ruderman #RWCS2020 @RWCSmtg https://t.co/0bbkyfVHE9
  8. Some improvement with lateral wedge insoles on function but not pain in one OA. Dr E Ruderman #RWCS2020 @RWCSmtg https://t.co/oL9I4f4Kap
  9. "EPI is wimpy and Sceritis is the real deal!". Dr AWells #RWCS @RWCSmtg https://t.co/4pHFjffixE Scleritis is a Vasculitis that requires systemic therapy https://t.co/QHknRcrLQy
  10. Teprotumumab effective in thyroid associated ophthalmopsthy it inhibits IGF 1 Dr AWells #RWCS @RWCSmtg https://t.co/eTHbAz0Eqp
  11. 66 pt RA study shows that adding an Exercise program results in significant physicial and cognitive improvement while lowering CRP (p = 0.025), fatigue (p = 0.047) and truncal fat (p = 0.004) https://t.co/hckGcM3pyL
  12. JBMR UK network study of 146,956 adults > 50 yrs compared Fracture Risk with tramadol (no cancer/Fx/Opioid disorder) compared to codeine (or naproxen, IBU, celecoxib, etoricoxib). Tramadol was assoc w/ a 28-70% higher Risk of hip Fx https://t.co/TPd9mTknqN
  13. Open label study of Abatacept in 79 patients with primary Sjogrens syndrome showed no difference between those treated wtih ABA vs Placebo. https://t.co/tUfAn40k9S
  14. DMARD Inertia by Registry Rheumatologists

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Rheumatologists' Comments

Treat to target in RA. Patient not doing as well as expected- check the methotrexate level!

More Like This

COVID-19 Susceptibility: Why Do Some Become So Ill?

The differential susceptibility to COVID-19 infection is attributable to socioeconomic factors and genetic differences, that together with environmental factors, human-virus interactions, gender, perhaps blood type, and age-related senescence determine the immune response and the likelihood of developing disease.

NICE Guidelines on Managing Rheumatologic Conditions During COVID-19 Pandemic

On April 3rd, the National Institute for Health and Care Excellence (NICE) in the UK, published a rapid guideline for managing children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection.

RheumNow Podcast – Pandemic Numbers (4.3.20)

Dr. Jack Cush reviews the news on COVID-19 and FDA actions this past week. Be sure to check out:

CDC: Impact of Underlying Health Conditions Among COVID-19 Patients

The March 31 release of the Morbidity and Mortality Weekly Report (MMWR) reviews the impact of several key comorbidities, most commonly diabetes mellitus, chronic lung disease, and cardiovascular disease, as cofactors leading to worse outcomes with COVID-19 infections.  Below are experts from that report.

TeleRheumatology - a TED Talk by Alvin Wells, MD

RheumNow Live 2020 featured a series of shorter STEP (TED-like) talks. This one features Dr. Alvin Wells discussing the opportunities and new paradigms encumbent with telemedicine in rheumatology.